个人简介
吴丽娟，女，医学博士研究生，硕士生导师，副教授
研究方向
主要研究方向为中医药对职业病、慢性疾病的机制研究，主持国家自然科学基金1项，主持及参研省部级、厅局级、校级等各级各类课题10余项，公开sci、北大核心等期刊论文近30余篇，第一作者/通讯作者发表文章12篇。
代表性成果
[1] wu lj, he xy, wang wx, et al. dahuang zhechong pills suppress silicosis fibrosis progression via p38 mapk/tgf-β1/smad pathway in vitro. evid based complement alternat med. 2021; 2021:6662261. published 2021 apr 1. doi:10.1155/2021/6662261
[2] wu lj, long l, sun jy, et al. exploring the antioxidant effect of lactobacillus plantarum scs2 on mice with type 2 diabetes [published online ahead of print, 2021 jul 18]. j food biochem. 2021; e13781. doi:10.1111/jfbc.13781
[3] wu lj, liu mj, liang jt, et al. ferroptosis as a new mechanism in parkinson's disease therapy using traditional chinese medicine. front pharmacol. 2021; 12:659584. published 2021 jun 7. doi:10.3389/fphar.2021.659584
[4] wu lj , he xy ,liang jt , liang j , wang f , chen dy，intragastric administration of dahuang zhechong pill modulates tgf-b1/ smad signaling pathway in murine model of experimental silicosis.journal of king saud university-science.32 (2020) 3223, 3229.https://doi.org/10.1016/j.jksus.
[5] he xy, wu lj, wang wx, xie pj, chen yh, wang f. amygdalin - a pharmacological and toxicological review. j ethnopharmacol. 2020; 254:112717. doi:10.1016/j.jep.2020.112717
[6] 吴丽娟,梁静涛,王飞.运用辛甘化阳法治疗抑郁症的理论探讨[j].四川中医,2021,39(11):37-39.
[7]梁静涛,霍之瀛,王敏,何晓艳,吴丽娟＊.大黄䗪虫丸抗多器官纤维化作用机制的研究进展[j].中国实验方剂学杂志,2021,27(16):237-244.doi:10.13422/j.cnki.syfjx.20211693.
[8] 吴丽娟,何晓艳,梁静涛,梁洁,张玉蝶.大黄䗪虫丸经p38 mapk/nf-κb/tgf-β_1通路抑制小鼠硅肺纤维化的机制探讨[j].中国实验方剂学杂志,2021,27(11):27-34.doi:10.13422/j.cnki.syfjx.20211190.
[9] 梁静涛,何晓艳,吴丽娟＊. 基于“异病同治”理论探讨当归芍药散经cox-2/pgf(2α)轴治疗原发性痛经和阿尔茨海默病的作用机制[j]. 四川中医,2022,06:36-40.